Balance Sheet AMETEK, Inc.

Equities

AME

US0311001004

Electrical Components & Equipment

Real-time Estimate Cboe BZX Other stock markets 15:23:02 2025-07-15 EDT			5-day change	1st Jan Change
177.08 ^USD	-0.71%		-2.29%	-1.71%

07-14	Morgan Stanley Raises Price Target on AMETEK to $185 From $170, Maintains Outperform Rating	MT
06-02	Cornerstone Building Brands, Inc Appoints Suzanne Stefany as Member of Its Board of Directors and Committee's, Effective June 1, 2025	CI

9ffc98037a19434761b4757885.mXMP2t0ZwD7LMw3_9aZqbHR0MBjTZqXf_zKdVitmSf4.7jVgg7x1gXWYV2SItOJSGiUWYSznP8HnqljELhNXK5HTF1CZgk2fbLl0WA

Published financial data: AMETEK, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Revenues	4.54B	5.55B	6.15B	6.6B	6.94B
Total Revenues	4.54B	5.55B	6.15B	6.6B	6.94B
Cost of Goods Sold, Total	2.95B	3.63B	4.01B	4.21B	4.46B
Gross Profit	1.59B	1.91B	2.15B	2.38B	2.48B
Selling General & Admin Expenses, Total	538M	604M	645M	677M	697M
Depreciation & Amortization - (IS)	-	-	-	-	-
Other Operating Expenses, Total	538M	604M	645M	677M	697M
Operating Income	1.05B	1.31B	1.5B	1.71B	1.78B
Interest Expense, Total	-86.06M	-80.38M	-83.19M	-81.8M	-113M
Interest And Investment Income	2.7M	2M	1M	12M	6.8M
Net Interest Expenses	-83.36M	-78.38M	-82.19M	-69.8M	-106M
Other Non Operating Income (Expenses)	19.45M	-13.47M	6.6M	-31.25M	-11.86M
EBT, Excl. Unusual Items	985M	1.22B	1.43B	1.61B	1.66B
Restructuring Charges	-43.9M	-	-	-	-
Gain (Loss) On Sale Of Assets	141M	6.35M	3.58M	-	-
Asset Writedown	-	-	-	-	-
EBT, Incl. Unusual Items	1.08B	1.22B	1.43B	1.61B	1.66B
Income Tax Expense	210M	233M	269M	293M	285M
Earnings From Continuing Operations	872M	990M	1.16B	1.31B	1.38B
Net Income to Company	872M	990M	1.16B	1.31B	1.38B
Net Income - (IS)	872M	990M	1.16B	1.31B	1.38B
Net Income to Common Incl Extra Items	872M	990M	1.16B	1.31B	1.38B
Net Income to Common Excl. Extra Items	872M	990M	1.16B	1.31B	1.38B
Per Share Items
Net EPS - Basic	3.8	4.29	5.04	5.7	5.95
Basic EPS - Continuing Operations	3.8	4.29	5.04	5.7	5.95
Basic Weighted Average Shares Outstanding	229M	231M	230M	231M	231M
Net EPS - Diluted	3.77	4.25	5.01	5.67	5.93
Diluted EPS - Continuing Operations	3.77	4.25	5.01	5.67	5.93
Diluted Weighted Average Shares Outstanding	231M	233M	232M	232M	232M
Normalized Basic EPS	2.68	3.29	3.87	4.36	4.49
Normalized Diluted EPS	2.66	3.27	3.85	4.34	4.47
Dividend Per Share	0.72	0.8	0.88	1	1.12
Payout Ratio	18.92	18.64	17.44	17.54	18.81
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	1.3B	1.6B	1.82B	2.05B	2.16B
EBITA	1.2B	1.49B	1.71B	1.92B	2.03B
EBIT	1.05B	1.31B	1.5B	1.71B	1.78B
EBITDAR	1.35B	1.67B	1.89B	2.12B	2.25B
Effective Tax Rate - (Ratio)	19.39	19.06	18.84	18.25	17.18
Current Domestic Taxes	146M	116M	218M	241M	143M
Current Foreign Taxes	61.67M	147M	119M	144M	155M
Total Current Taxes	208M	263M	337M	385M	298M
Deferred Domestic Taxes	5.91M	26.81M	-47M	-76.79M	1.37M
Deferred Foreign Taxes	-4.07M	-56.57M	-20.82M	-15.11M	-14.32M
Total Deferred Taxes	1.84M	-29.76M	-67.82M	-91.9M	-12.94M
Normalized Net Income	616M	761M	891M	1B	1.04B
Interest Capitalized	-	-	-	-	-
Interest on Long-Term Debt	-	-	-	-	-
Non-Cash Pension Expense	-16.05M	-18.26M	-31.41M	-10.41M	-16.86M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	246M	300M	322M	352M	372M
Net Rental Expense, Total	49.02M	69.4M	70.39M	74.43M	88.04M
Imputed Operating Lease Interest Expense	12.18M	16.82M	17.74M	15.92M	27.06M
Imputed Operating Lease Depreciation	36.84M	52.59M	52.65M	58.51M	60.99M
Stock-Based Comp., SG&A Exp. (Total)	-	-	-	-	-
Stock-Based Comp., Other (Total)	41.56M	46.1M	47.38M	46.2M	47.86M
Total Stock-Based Compensation	41.56M	46.1M	47.38M	46.2M	47.86M

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	1.21B	347M	345M	410M	374M
Total Cash And Short Term Investments	1.21B	347M	345M	410M	374M
Accounts Receivable, Total	666M	924M	1.04B	1.07B	986M
Total Receivables	666M	924M	1.04B	1.07B	986M
Inventory	559M	769M	1.04B	1.13B	1.02B
Deferred Tax Assets Current	-	-	-	-	-
Other Current Assets, Total	84.03M	88.33M	99.31M	212M	221M
Total Current Assets	2.52B	2.13B	2.53B	2.82B	2.6B
Gross Property Plant And Equipment	1.62B	1.7B	1.79B	2.23B	2.2B
Accumulated Depreciation	-928M	-918M	-986M	-1.11B	-1.14B
Net Property Plant And Equipment	694M	787M	806M	1.12B	1.05B
Long-term Investments	8.97M	10.7M	9.86M	11.92M	143M
Goodwill	4.22B	5.24B	5.37B	6.45B	6.56B
Other Intangibles, Total	2.62B	3.37B	3.34B	4.17B	3.92B
Deferred Tax Assets Long-Term	12.1M	27M	50.87M	74.29M	78.14M
Other Long-Term Assets, Total	272M	337M	322M	379M	281M
Total Assets	10.36B	11.9B	12.43B	15.02B	14.63B
Liabilities
Accounts Payable, Total	360M	470M	497M	517M	523M
Accrued Expenses, Total	124M	206M	213M	228M	203M
Short-term Borrowings	-	-	-	-	-
Current Portion of Long-Term Debt	132M	315M	226M	1.42B	654M
Current Portion of Leases	44.95M	47.35M	46.37M	61.06M	54.74M
Current Income Taxes Payable	38.9M	35.9M	48.17M	69.57M	84.43M
Unearned Revenue Current, Total	195M	299M	358M	376M	364M
Other Current Liabilities	180M	190M	175M	214M	216M
Total Current Liabilities	1.08B	1.56B	1.56B	2.88B	2.1B
Long-Term Debt	2.28B	2.23B	2.16B	1.9B	1.43B
Long-Term Leases	128M	129M	129M	182M	190M
Unearned Revenue Non Current	20.5M	30.1M	41M	57.3M	37.1M
Deferred Tax Liability Non Current	533M	720M	694M	837M	831M
Other Non Current Liabilities	369M	355M	367M	439M	394M
Total Liabilities	4.41B	5.03B	4.95B	6.29B	4.98B
Common Stock, Total	2.68M	2.69M	2.7M	2.71M	2.72M
Additional Paid In Capital	922M	1.01B	1.09B	1.17B	1.26B
Retained Earnings	7.09B	7.9B	8.86B	9.94B	11.06B
Treasury Stock	-1.57B	-1.57B	-1.9B	-1.9B	-2.11B
Comprehensive Income and Other	-504M	-470M	-575M	-485M	-556M
Total Common Equity	5.95B	6.87B	7.48B	8.73B	9.66B
Total Equity	5.95B	6.87B	7.48B	8.73B	9.66B
Total Liabilities And Equity	10.36B	11.9B	12.43B	15.02B	14.63B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	231M	232M	230M	231M	231M
ECS Total Common Shares Outstanding	231M	232M	230M	231M	231M
Book Value / Share	25.81	29.66	32.5	37.8	41.85
Tangible Book Value	-899M	-1.74B	-1.24B	-1.88B	-816M
Tangible Book Value Per Share	-3.9	-7.49	-5.38	-8.15	-3.54
Total Debt	2.59B	2.72B	2.56B	3.56B	2.32B
Net Debt	1.37B	2.37B	2.22B	3.15B	1.95B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-29.09M	-131M	-147M	-193M	-96.9M
Debt Equivalent Oper. Leases	392M	555M	563M	595M	704M
Account Code - Inventory Valuation	5	5	5	5	5
LIFO Reserve, Total	-22.8M	-29.8M	-40.3M	-39M	-40.8M
Inventories - Raw Materials, Total	375M	557M	775M	831M	770M
Inventories - Work In Process, Total	103M	122M	138M	166M	171M
Inventories - Finished Goods, Total	81.62M	89.98M	131M	136M	80.49M
Land - (BS)	33.38M	41.71M	55.92M	67.2M	67.64M
Buildings, Total	302M	344M	366M	455M	449M
Machinery, Total	1.12B	1.15B	1.2B	1.48B	1.44B
Full Time Employees	16.5K	18.5K	19.6K	21.5K	21.5K
Accumulated Allowance for Doubtful Accounts (Supple)	12.7M	11.2M	14.1M	13.2M	13.03M
Order Backlog	1.8B	2.73B	3.22B	3.53B	3.4B

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	872M	990M	1.16B	1.31B	1.38B
Depreciation & Amortization - CF	101M	109M	114M	123M	135M
Amortization of Goodwill and Intangible Assets - (CF)	154M	184M	206M	215M	248M
Depreciation & Amortization, Total	255M	292M	319M	338M	383M
(Gain) Loss From Sale Of Asset	-149M	-6.35M	-10.64M	-120K	-995K
Asset Writedown & Restructuring Costs	-	-	-	-	-
Stock-Based Compensation (CF)	41.56M	46.1M	47.38M	46.2M	47.86M
Other Operating Activities, Total	-8.12M	-36.08M	-99.86M	-104M	-43.74M
Change In Accounts Receivable	163M	-173M	-86.71M	8.45M	53.49M
Change In Inventories	77.45M	-130M	-322M	56.62M	73M
Change In Accounts Payable	7.02M	212M	95.48M	10.43M	-18.48M
Change in Other Net Operating Assets	20.43M	-35.1M	47.23M	67.28M	-41.33M
Cash from Operations	1.28B	1.16B	1.15B	1.74B	1.83B
Capital Expenditure	-74.2M	-111M	-139M	-136M	-127M
Sale of Property, Plant, and Equipment	9.51M	2.34M	11.75M	880K	4.25M
Cash Acquisitions	-117M	-1.96B	-430M	-2.24B	-118M
Divestitures	245M	12M	3.73M	-	-
Other Investing Activities, Total	-2.48M	-294K	471K	-3.15M	-4.46M
Cash from Investing	61.63M	-2.06B	-553M	-2.38B	-245M
Short Term Debt Issued, Total	-	244M	-	892M	-
Long-Term Debt Issued, Total	-	-	-	-	-
Total Debt Issued	-	244M	-	892M	-
Short Term Debt Repaid, Total	-328M	-	-73.69M	-	-890M
Long-Term Debt Repaid, Total	-103M	-59.72M	-	-	-300M
Total Debt Repaid	-431M	-59.72M	-73.69M	-	-1.19B
Issuance of Common Stock	64.9M	60.3M	49.94M	50.85M	66.87M
Repurchase of Common Stock	-4.68M	-14.71M	-333M	-7.77M	-212M
Common Dividends Paid	-165M	-185M	-202M	-230M	-259M
Common & Preferred Stock Dividends Paid	-165M	-185M	-202M	-230M	-259M
Other Financing Activities, Total	-3.67M	-5.55M	-16.96M	-7.75M	-8.78M
Cash from Financing	-539M	39.34M	-576M	697M	-1.6B
Foreign Exchange Rate Adjustments	16.62M	-10M	-22.3M	8.27M	-17.39M
Net Change in Cash	820M	-866M	-1.39M	64.42M	-35.8M
Supplemental Items
Cash Interest Paid	86.2M	78.7M	80.2M	66.3M	114M
Cash Income Tax Paid (Refund)	210M	246M	299M	336M	302M
Levered Free Cash Flow	1.16B	825M	804M	1.14B	1.52B
Unlevered Free Cash Flow	1.21B	875M	856M	1.19B	1.59B
Change In Net Working Capital	-336M	170M	310M	120M	-172M
Net Debt Issued / Repaid	-431M	184M	-73.69M	892M	-1.19B

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	6.49	7.35	7.71	7.77	7.5
Return on Total Capital	7.9	9.02	9.56	9.56	9.17
Return On Equity %	15.77	15.44	16.16	16.21	14.97
Return on Common Equity	15.77	15.44	16.16	16.21	14.97
Margin Analysis
Gross Profit Margin %	34.96	34.48	34.88	36.14	35.68
SG&A Margin	11.85	10.89	10.48	10.26	10.04
EBITDA Margin %	28.73	28.86	29.59	31	31.15
EBITA Margin %	26.5	26.9	27.75	29.14	29.21
EBIT Margin %	23.11	23.59	24.4	25.88	25.64
Income From Continuing Operations Margin %	19.22	17.85	18.85	19.91	19.83
Net Income Margin %	19.22	17.85	18.85	19.91	19.83
Net Avail. For Common Margin %	19.22	17.85	18.85	19.91	19.83
Normalized Net Income Margin	13.56	13.71	14.48	15.22	14.96
Levered Free Cash Flow Margin	25.57	14.88	13.07	17.33	21.86
Unlevered Free Cash Flow Margin	26.76	15.78	13.92	18.11	22.87
Asset Turnover
Asset Turnover	0.45	0.5	0.51	0.48	0.47
Fixed Assets Turnover	6.38	7.49	7.72	6.85	6.38
Receivables Turnover (Average Receivables)	6.12	6.97	6.26	6.5	6.75
Inventory Turnover (Average Inventory)	4.99	5.47	4.42	3.87	4.15
Short Term Liquidity
Current Ratio	2.34	1.36	1.62	0.98	1.24
Quick Ratio	1.75	0.81	0.89	0.51	0.65
Operating Cash Flow to Current Liabilities	1.19	0.74	0.73	0.6	0.87
Days Sales Outstanding (Average Receivables)	59.83	52.35	58.26	56.17	54.21
Days Outstanding Inventory (Average Inventory)	73.36	66.71	82.63	94.3	88.3
Average Days Payable Outstanding	46.75	39.44	41.25	43.02	43.71
Cash Conversion Cycle (Average Days)	86.44	79.62	99.65	107.46	98.8
Long Term Solvency
Total Debt/Equity	43.48	39.59	34.25	40.74	24.07
Total Debt / Total Capital	30.3	28.36	25.51	28.95	19.4
LT Debt/Equity	40.5	34.32	30.6	23.8	16.73
Long-Term Debt / Total Capital	28.23	24.58	22.8	16.91	13.48
Total Liabilities / Total Assets	42.56	42.24	39.86	41.89	34.01
EBIT / Interest Expense	12.19	16.28	18.04	20.87	15.75
EBITDA / Interest Expense	15.73	20.78	22.73	25.91	19.92
(EBITDA - Capex) / Interest Expense	14.86	19.4	21.06	24.25	18.8
Total Debt / EBITDA	1.91	1.63	1.35	1.68	1.03
Net Debt / EBITDA	1.02	1.42	1.17	1.48	0.87
Total Debt / (EBITDA - Capex)	2.02	1.74	1.46	1.79	1.09
Net Debt / (EBITDA - Capex)	1.07	1.52	1.26	1.59	0.92
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-11.99	22.17	10.89	7.26	5.22
Gross Profit, 1 Yr. Growth %	-11.21	20.5	12.16	11.15	3.86
EBITDA, 1 Yr. Growth %	-5.34	20.64	13.7	12.36	5.74
EBITA, 1 Yr. Growth %	-5.76	21.76	14.36	12.66	5.45
EBIT, 1 Yr. Growth %	-8.29	22.12	14.67	13.78	4.22
Earnings From Cont. Operations, 1 Yr. Growth %	1.29	13.48	17.12	13.25	4.79
Net Income, 1 Yr. Growth %	1.29	13.48	17.12	13.25	4.79
Normalized Net Income, 1 Yr. Growth %	-7.9	23.54	17.12	12.72	3.43
Diluted EPS Before Extra, 1 Yr. Growth %	0.53	12.73	17.88	13.17	4.59
Accounts Receivable, 1 Yr. Growth %	-18.51	38.72	12.39	11.44	-7.88
Inventory, 1 Yr. Growth %	-10.47	37.56	35.77	8.44	-9.78
Net Property, Plant and Equip., 1 Yr. Growth %	-4.78	13.45	2.4	39.09	-5.95
Total Assets, 1 Yr. Growth %	5.21	14.88	4.48	20.85	-2.61
Tangible Book Value, 1 Yr. Growth %	-46.94	92.98	-28.66	52.06	-56.67
Common Equity, 1 Yr. Growth %	16.3	15.51	8.8	16.77	10.6
Cash From Operations, 1 Yr. Growth %	14.95	-9.41	-0.96	50.98	5.39
Capital Expenditures, 1 Yr. Growth %	-27.5	49.15	25.6	-1.98	-6.73
Levered Free Cash Flow, 1 Yr. Growth %	74.12	-29.78	-2.56	42.21	32.69
Unlevered Free Cash Flow, 1 Yr. Growth %	68.23	-28.77	-2.21	39.54	32.93
Dividend Per Share, 1 Yr. Growth %	28.57	11.11	10	13.64	12
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-3.21	3.69	16.39	9.06	6.23
Gross Profit, 2 Yr. CAGR %	-2.2	3.44	17.89	11.66	7.44
EBITDA, 2 Yr. CAGR %	1.68	6.5	19.1	13.03	9
EBITA, 2 Yr. CAGR %	1.14	6.73	20.16	13.51	8.99
EBIT, 2 Yr. CAGR %	-0.62	5.43	20.83	14.22	8.9
Earnings From Cont. Operations, 2 Yr. CAGR %	5.9	7.21	15.29	15.17	8.94
Net Income, 2 Yr. CAGR %	5.9	7.21	15.29	15.17	8.94
Normalized Net Income, 2 Yr. CAGR %	-0.13	6.65	23.04	14.9	7.98
Diluted EPS Before Extra, 2 Yr. CAGR %	6.24	6.46	15.28	15.5	8.79
Accounts Receivable, 2 Yr. CAGR %	-8.22	6.32	24.87	7.59	1.32
Inventory, 2 Yr. CAGR %	-5.39	10.97	36.66	21.34	-1.09
Net Property, Plant and Equip., 2 Yr. CAGR %	11.89	3.94	7.78	19.34	14.37
Total Assets, 2 Yr. CAGR %	9.35	9.94	9.55	12.37	8.49
Tangible Book Value, 2 Yr. CAGR %	-28.8	1.19	17.34	4.16	-18.83
Common Equity, 2 Yr. CAGR %	18.43	15.9	12.1	12.71	13.64
Cash From Operations, 2 Yr. CAGR %	17.65	2.04	-5.28	22.28	26.14
Capital Expenditures, 2 Yr. CAGR %	-4.92	3.99	36.87	10.96	-4.39
Levered Free Cash Flow, 2 Yr. CAGR %	35.46	9.54	-16.3	17.72	37.37
Unlevered Free Cash Flow, 2 Yr. CAGR %	33.26	8.54	-15.6	16.81	36.19
Dividend Per Share, 2 Yr. CAGR %	13.39	19.52	10.55	11.8	12.82
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	1.83	4.6	6.04	13.26	7.76
Gross Profit, 3 Yr. CAGR %	3.33	4.84	6.27	15.6	8.99
EBITDA, 3 Yr. CAGR %	6.89	8.26	8.85	16.81	10.55
EBITA, 3 Yr. CAGR %	6.85	8.26	9.21	17.61	10.75
EBIT, 3 Yr. CAGR %	5.84	7.21	8.42	18.43	10.79
Earnings From Cont. Operations, 3 Yr. CAGR %	8.58	8.37	10.42	14.6	11.6
Net Income, 3 Yr. CAGR %	8.58	8.37	10.42	14.6	11.6
Normalized Net Income, 3 Yr. CAGR %	7.33	7.2	10.03	19.5	10.94
Diluted EPS Before Extra, 3 Yr. CAGR %	8.64	8.36	10.14	14.57	11.74
Accounts Receivable, 3 Yr. CAGR %	-0.77	5.33	8.31	17.1	2.17
Inventory, 3 Yr. CAGR %	1.14	7.18	18.69	26.52	9.93
Net Property, Plant and Equip., 3 Yr. CAGR %	12.04	12.41	3.42	17.35	10.23
Total Assets, 3 Yr. CAGR %	9.93	11.16	8.09	13.2	7.14
Tangible Book Value, 3 Yr. CAGR %	-6.53	-0.73	-9.94	27.93	-22.25
Common Equity, 3 Yr. CAGR %	13.89	17.45	13.48	13.64	12
Cash From Operations, 3 Yr. CAGR %	15.41	7.83	1.03	10.65	16.37
Capital Expenditures, 3 Yr. CAGR %	-0.39	10.48	10.74	22.46	4.72
Levered Free Cash Flow, 3 Yr. CAGR %	16.58	9.25	5.35	-0.13	22.51
Unlevered Free Cash Flow, 3 Yr. CAGR %	15.23	8.57	4.83	-0.2	21.96
Dividend Per Share, 3 Yr. CAGR %	25.99	12.62	16.26	11.57	11.87
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	2.7	7.63	7.42	6.36	6.12
Gross Profit, 5 Yr. CAGR %	2.66	8.15	8.32	7.52	6.74
EBITDA, 5 Yr. CAGR %	3.58	9.71	11.25	10.14	8.91
EBITA, 5 Yr. CAGR %	3.25	9.86	11.59	10.33	9.13
EBIT, 5 Yr. CAGR %	2.13	9.24	11.14	9.96	8.61
Earnings From Cont. Operations, 5 Yr. CAGR %	8.11	14.09	11.22	11.04	9.82
Net Income, 5 Yr. CAGR %	8.11	14.09	11.22	11.04	9.82
Normalized Net Income, 5 Yr. CAGR %	3.17	10.68	12.33	10.22	9.21
Diluted EPS Before Extra, 5 Yr. CAGR %	9	14.18	11.25	11.16	9.6
Accounts Receivable, 5 Yr. CAGR %	2.01	9.31	8.78	6.23	3.81
Inventory, 5 Yr. CAGR %	1.68	9.34	14.08	12.63	10.34
Net Property, Plant and Equip., 5 Yr. CAGR %	7.44	10.71	10.32	15.13	7.67
Total Assets, 5 Yr. CAGR %	9.23	10.88	9.78	11.64	8.25
Tangible Book Value, 5 Yr. CAGR %	-4.38	6.01	2.37	1.2	-13.61
Common Equity, 5 Yr. CAGR %	12.82	16.11	13.17	15.53	13.55
Cash From Operations, 5 Yr. CAGR %	13.75	8.92	6.64	13.4	10.41
Capital Expenditures, 5 Yr. CAGR %	1.44	11.83	13.11	10.67	4.42
Levered Free Cash Flow, 5 Yr. CAGR %	14.52	5.72	1.87	12.56	17.15
Unlevered Free Cash Flow, 5 Yr. CAGR %	13.44	5.06	1.52	11.79	16.4
Dividend Per Share, 5 Yr. CAGR %	14.87	17.32	19.57	12.3	14.87